Home The Word Brain | My Amedeo FAQ Privacy About | ||||||||||
The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al. |
Vaccines |
Free Subscription
1 Clin Infect Dis |
Retrieve available abstracts of this week’s articles:
HTML format |
Single Articles |
AMEDEO Vaccines is free of charge.
Early Mortality After the First Dose of Coronavirus Disease 2019 Vaccination: A
Target Trial Emulation.
Clin Infect Dis. 2024 Feb 6:ciad604. doi: 10.1093.
PubMed
Abstract available
BECC438b TLR4 agonist supports unique immune response profiles from nasal and
muscular DTaP pertussis vaccines in murine challenge models.
Infect Immun. 2024 Feb 7:e0022323. doi: 10.1128/iai.00223.
PubMed
Abstract available
Meningococcal disease in the Middle East: A report from the Global Meningococcal
Initiative.
J Infect. 2024;88:71-76.
PubMed
Abstract available
Recombinant full-length Plasmodium falciparum circumsporozoite protein-based
vaccine adjuvanted with GLA-LSQ: Results of Phase 1 testing with malaria
challenge.
J Infect Dis. 2024 Feb 8:jiae062. doi: 10.1093.
PubMed
Abstract available
Correlates of Rotavirus Vaccine Shedding and Seroconversion in a U.S. Cohort of
Healthy Infants.
J Infect Dis. 2024 Feb 8:jiae055. doi: 10.1093.
PubMed
Abstract available
Human Cytomegalovirus mRNA-1647 Vaccine Candidate Elicits Potent and Broad
Neutralization and Higher Antibody-Dependent Cellular Cytotoxicity Responses Than
the gB/MF59 Vaccine.
J Infect Dis. 2024 Feb 7:jiad593. doi: 10.1093.
PubMed
Abstract available
Africa's First Routine Malaria Vaccination Campaign Begins.
JAMA. 2024 Feb 7. doi: 10.1001/jama.2024.0170.
PubMed
Neonatal Outcomes After COVID-19 Vaccination in Pregnancy.
JAMA. 2024;331:396-407.
PubMed
Abstract available
Effectiveness of Bivalent mRNA COVID-19 Vaccines in Preventing SARS-CoV-2
Infection in Children and Adolescents Aged 5 to 17 Years.
JAMA. 2024;331:408-416.
PubMed
Abstract available
Routine malaria vaccinations begin.
Lancet. 2024;403:423.
PubMed
Safety and efficacy of malaria vaccine candidate R21/Matrix-M in African
children: a multicentre, double-blind, randomised, phase 3 trial.
Lancet. 2024 Feb 1:S0140-6736(23)02511-4. doi: 10.1016/S0140-6736(23)02511.
PubMed
Abstract available
Malaria vaccines for children: and now there are two.
Lancet. 2024 Feb 1:S0140-6736(23)02743-5. doi: 10.1016/S0140-6736(23)02743.
PubMed
The Risks of Normalizing Parental Vaccine Hesitancy.
N Engl J Med. 2024;390:485-487.
PubMed
Maternal COVID-19 Vaccination and Prevention of Symptomatic Infection in Infants.
Pediatrics. 2024 Feb 9:e2023064252. doi: 10.1542/peds.2023-064252.
PubMed
Abstract available
Knowledge, attitude and perception towards COVID-19 among representative educated
sub-Saharan Africans: A cross-sectional study during the exponential phase of the
pandemic.
PLoS One. 2024;19:e0281342.
PubMed
Abstract available
High-risk HPV prevalence and vaccination coverage among Indigenous women in the
Colombian Amazon: Implications for cervical cancer prevention. Cross-sectional
study.
PLoS One. 2024;19:e0297579.
PubMed
Abstract available
Diminished measles immunity after paediatric liver transplantation-A
retrospective, single-centre, cross-sectional analysis.
PLoS One. 2024;19:e0296653.
PubMed
Abstract available
Spatial pattern and associated factors of timely vaccination in Ethiopia using
EDHS-2016 data: A multilevel and spatial analysis.
PLoS One. 2024;19:e0296123.
PubMed
Abstract available
How does COVID-19 vaccination affect long-COVID symptoms?
PLoS One. 2024;19:e0296680.
PubMed
Abstract available
Design of universal Ebola virus vaccine candidates via immunofocusing.
Proc Natl Acad Sci U S A. 2024;121:e2316960121.
PubMed
Abstract available
Resurgent rotavirus diarrhoea outbreak five years after introduction of rotavirus
vaccine in Botswana, 2018.
Vaccine. 2024 Feb 7:S0264-410X(24)00108-7. doi: 10.1016/j.vaccine.2024.
PubMed
Abstract available
Prokaryote-derived phosphorylated Tau epitope vaccine is immunogenic and
non-T-cell activated in the mice model.
Vaccine. 2024 Feb 7:S0264-410X(23)01517-7. doi: 10.1016/j.vaccine.2023.
PubMed
Abstract available
Public opinion on global COVID-19 vaccine procurement and distribution policies:
A nationally representative survey in Aotearoa New Zealand 2022.
Vaccine. 2024 Feb 6:S0264-410X(24)00115-4. doi: 10.1016/j.vaccine.2024.
PubMed
Abstract available
Report from the World Health Organization's immunization and vaccines related
implementation research advisory committee (IVIR-AC) meeting, Geneva, 11-13
September 2023.
Vaccine. 2024 Feb 6:S0264-410X(24)00160-9. doi: 10.1016/j.vaccine.2024.
PubMed
Abstract available
A review of potential use cases for measles-rubella, measles-mumps-rubella, and
typhoid-conjugate vaccines presented on microarray patches.
Vaccine. 2024 Feb 6:S0264-410X(23)01493-7. doi: 10.1016/j.vaccine.2023.
PubMed
Abstract available
Addressing cultural and political drivers of vaccine hesitancy: Considerations
for the African and Asian contexts.
Vaccine. 2024 Feb 6:S0264-410X(24)00159-2. doi: 10.1016/j.vaccine.2024.
PubMed
Determinants of immunization in polio super high-risk union councils of Pakistan.
Vaccine. 2024;42:583-590.
PubMed
Abstract available
Heat-inactivated mycobacteria activate the toll-like receptor 2 and 4 pathways in
the zebrafish model of tuberculosis.
Vaccine. 2024;42:403-409.
PubMed
Abstract available
Exploring preventive care practices among unvaccinated individuals in the United
States during the COVID-19 pandemic.
Vaccine. 2024;42:441-447.
PubMed
Abstract available
Infection-mediated immune response in SARS-CoV-2 breakthrough infection and
implications for next-generation COVID-19 vaccine development.
Vaccine. 2024 Feb 2:S0264-410X(24)00112-9. doi: 10.1016/j.vaccine.2024.
PubMed
Abstract available
Development of a live-attenuated chimeric vaccine against the emerging Usutu
virus.
Vaccine. 2024 Feb 2:S0264-410X(24)00098-7. doi: 10.1016/j.vaccine.2024.
PubMed
Abstract available
Protective effect against toxoplasmosis in BALB/C mice vaccinated with
recombinant Toxoplasma gondii CDPK3, GRA35, and ROP46 protein cocktail vaccine.
Vaccine. 2024 Feb 2:S0264-410X(24)00062-8. doi: 10.1016/j.vaccine.2024.
PubMed
Abstract available
One-year follow-up of the immunogenicity and safety of a primary series of the
NVX-CoV2373 (TAK-019) vaccine in healthy Japanese adults: Final report of a phase
I/II randomized controlled trial.
Vaccine. 2024 Feb 2:S0264-410X(24)00068-9. doi: 10.1016/j.vaccine.2024.
PubMed
Abstract available
Live attenuated smallpox vaccine candidate (KVAC103) efficiently induces
protective immune responses in mice.
Vaccine. 2024 Feb 2:S0264-410X(24)00076-8. doi: 10.1016/j.vaccine.2024.
PubMed
Abstract available
Value of information dynamics in Disease X vaccine clinical trials.
Vaccine. 2024 Feb 3:S0264-410X(24)00075-6. doi: 10.1016/j.vaccine.2024.
PubMed
Abstract available
A DNA vaccine against GII.4 human norovirus VP1 induces blocking antibody
production and T cell responses.
Vaccine. 2024 Feb 5:S0264-410X(24)00114-2. doi: 10.1016/j.vaccine.2024.
PubMed
Abstract available
The age-specific impact of COVID-19 vaccination on medical expenditures and
hospitalization duration after breakthrough infection: The Vaccine Effectiveness,
Networking, and Universal Safety (VENUS) Study.
Vaccine. 2024 Feb 5:S0264-410X(24)00106-3. doi: 10.1016/j.vaccine.2024.
PubMed
Abstract available
Thank you for your interest in scientific medicine.